182 recalls
across 60 of 950 AI devices
What the research found
A study of 950 FDA-authorised AI devices found 60 tied to 182 recall events. The vast majority of recalled devices had no clinical validation, and about 43% of recalls occurred within a year of authorisation — most having cleared via a pathway that requires no prospective human testing.
Why it matters for providers
Regulatory clearance is not proof of safety. 'Cleared' and 'proven' are different words, and the gap is where patients live.
Original source
JAMA Health Forum
Peer-reviewed or official source — the most reliable tier.